You may not know Athena Stevens’s name, but you may remember her legal troubles: her allegations against Shakespeare's Globe ...

Explore How iGenics, a 2025 Top-Rated Vision Supplement, Combats Macular Degeneration, Blue Light Exposure, and Digital Eye ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

Incorporating chest CT imaging and respiratory symptoms into the chronic obstructive pulmonary disease (COPD) diagnostic ...

While the research focused on visual attention, joint attention involves multiple behaviors beyond eye gaze, including gestures and vocalizations, which weren’t comprehensively analyzed. These ...

All patients with a central corneal pathology and best corrected visual acuity of less than 20/200 in the ... Overall, 60.1% of affected eyes carried a fair to poor prognosis for keratoplasty. However ...

After his diagnosis, Gormly had surgery to remove the tumor and was back to work within 10 days. An early version of Guardant Health's Shield test has been commercially available since 2022 ...

Conclusion: The diagnosis is often delayed in NSAOA, and the overall visual prognosis is poor. Older age, longer symptom duration, worse baseline vision, thinner RNFL thickness, and lower CSF VDRL ...

Despite initial poor visual acuity, most showed significant ... optimal treatment strategies, and long-term prognosis. Identifying specific biomarkers, including potential novel antiretinal ...

Nonarteritic CRAO has poor visual prognosis regardless of conservative interventions or how soon after symptom onset a patient presents for care. Neither earlier time-to-presentation nor conservative ...